Table 2 Patient outcomes.
From: Acquired factor XIII deficiency in adult patients during ECMO: a prospective observational study
N | 44 | |
|---|---|---|
Complications during ECMO | ||
Major bleeding event | n (%) | 33 (75.0) |
Thromboembolic event | n (%) | 12 (27.3) |
Number of pRBC units transfused during ECMO | Units | 10 (6–19) |
Early pRBC transfusion exposure (< 24 h after ECMO start) | Units | 2 (0–3) |
Later pRBC transfusion exposure (> 24 h hours after ECMO start | Units | 8 (6–16) |
Duration of ECMO | Days | 9 (6–13) |
Bridging to assist device | n (%) | 3 (6.8) |
Bridging to transplant | n (%) | 4 (9.1) |
Intensive care unit length of stay | Days | 16 (13–25) |
Mortality | ||
Intensive care unit mortality | n (%) | 10 (22.7) |
28-day mortality | n (%) | 10 (22.7) |
Hospital mortality | n (%) | 11 (25.0) |
